Rezolute, Inc.
RZLT Nasdaq· Pharmaceutical Preparations
Last close · Oct 26, 2026
$3.82
KIRA · Stoqly’s AI analyst, in plain words
- Rezolute, Inc. lost $77.6M in fiscal 2026.
Market cap
$397M
P/E
—
Revenue
—
Net income
−$77.6M
Free cash flow
—
Operating margin
—
Rezolute, Inc. in 30 seconds · fiscal 2026
Does it make a profit?
−$77.6M
No. It lost money last year.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Rezolute, Inc. does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Sep 24, 2026
- Legal name
- Rezolute, Inc.
- CIK
- 0001509261
Rezolute, Inc. · RZLT
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | −$41.1M | −$51.8M | −$68.5M | −$74.4M | −$77.6M |
| Diluted EPS | −$2.32 | −$1.01 | −$1.33 | −$0.98 | −$0.75 |
| Cash | |||||
| Cash from operations | −$39.6M | −$44.5M | −$57.4M | −$69.1M | −$64.6M |
| Capital expenditure | — | $0.2M | — | — | — |
| Free cash flow | — | −$44.6M | — | — | — |
| Share buybacks | — | — | $0.0M | — | — |
| Share count change | 154.0% | 162.7% | 0.5% | 47.7% | 36.7% |
| Debt and strength | |||||
| Cash and short-term investments | $150M | $102M | $127M | $168M | $108M |
| Shareholders' equity | $149M | $116M | $121M | $162M | $101M |
| Current ratio | 61.8x | 20.2x | 13.4x | 14.4x | 9.7x |
| Returns and quality | |||||
| Return on equity | −46.8% | −39.0% | −57.7% | −52.6% | −59.0% |
| Return on tangible equity | −27.5% | −44.6% | −56.6% | −45.9% | −77.1% |
| Altman Z'' | 53.3 | 11.5 | 5.1 | 8.1 | −4.4 |
Insiders bought, 12 months
$0.2M
5 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Rezolute, Inc. · RZLT
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.82 a share, the company is worth $397M.
Source: SEC EDGAR XBRL filings (CIK 0001509261). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.